Market Place
Sourcing Support
Onxeo Appoints Dr. Shefali Agarwal as President and Chief Executive Officer
06 Apr 2022 //
BUSINESSWIRE
Onxeo Further strengthens its Board of Directors two Seasoned Personalities
14 Oct 2021 //
GLOBENEWSWIRE
Onxeo Appointment of Dr. Shefali Agarwal as the Company Chairwoman of the Board
29 Jul 2021 //
GLOBENEWSWIRE
Onxeo Announces Completion of Patient Enrollment in DRIIV-1b Study
09 Nov 2020 //
GLOBENEWSWIRE
ONXEO RECEIVES NOTICE OF INTENT TO GRANT A NEW PATENT ENHANCING
23 Oct 2020 //
PRESS RELEASE
ONXEO ANNOUNCES ENROLLMENT OF FIRST PATIENT IN PHASE IB/II STUDY REVOCAN
21 Oct 2020 //
PRESS RELEASE
Onxeo Receives Allowance for New Patent Strengthening Protection of AsiDNA
03 Sep 2020 //
GLOBENEWSWIRE
Onxeo Reports Pub of Final Results of DRIIV Ph1 Dose-Escalation Study of AsiDNA™
27 Aug 2020 //
GLOBENEWSWIRE
Tizona Initiates Clinical Development of TTX-080 in Advanced Cancers
25 Jun 2020 //
GLOBENEWSWIRE
Onxeo Announces Approval of the REVocan Study by Regulatory Authorities
29 May 2020 //
GLOBENEWSWIRE
Onxeo to Present New Preclinical Data at AACR 2020 the Ability of AsiDNA™ t
19 May 2020 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.